Genomics|Tier 1 Genomic Applications Toolkit for Public Health Departments

Genomics|Tier 1 Genomic Applications Toolkit for Public Health Departments





Genomics|Update|Current

Hereditary Breast & Ovarian Cancer: Awareness, Implementation & Population Screening

Public Health Genomics Implementation Tool Kit for health departments- check out BRCA section

CDC initiative Know:BRCA. In the US, 9,000 women younger than 40 years are diagnosed every year with breast cancer.  In this younger group, breast cancer is generally more aggressive, found at a later stage, and has lower survival rates

CDC BRCA assessment tool for women: The Know:BRCA Assessment can help you assess your risk of having a BRCA mutation. Learning your risk can help you and your doctor make important decisions for your health

CDC BRCA assessment tool for clinicians: Help women Know: BRCA

CDC sponsored study findings: Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: A statewide initiative. 
Brannon Traxler L, et al. Ann Surg Oncol. 2014 Jul 22

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Efrat Gabai-Kapara et al. PNAS, September 4, 2014

Population-based screening for BRCA1 and BRCA2 
Mary-Claire King et al. JAMA, September 8, 2014 

Beyond family history: Should all women be screened for BRCA breast cancer genes? By Meredith Knight, Genetic Literacy Project, Sep 9

Researcher urges wider genetic screening for breast cancer, NPR, Sep 8

Lasker winner calls for more genetic testing for cancer, by Lawrence K. Altman et al. New York Times, Sept 8

NSGC responds to Journal of the American Medical Association study recommending genetic testing for breast and ovarian cancer for all women over 30, NSGC, Sep 9

Study of Jewish women shows link to cancer without family history, by Roni Caryn Rabin, New York Times, Sept 4

Angelina Jolie’s surgery may have doubled genetic testing rates at one clinic, by Alexandra Sifferlin, Time, Sept 2

The Angelina effect: immediate reach, grasp, and impact of going public. 
Dina L.G. Borzekowski et al. Genetics in Medicine (2013)